DRUGS FOR RARE DISEASES

被引:0
|
作者
不详
机构
来源
LANCET | 1976年 / 2卷 / 7990期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:835 / 836
页数:2
相关论文
共 50 条
  • [31] An Evaluation Framework for Funding Drugs for Rare Diseases
    Winquist, Eric
    Bell, Chaim M.
    Clarke, Joe T. R.
    Evans, Gerald
    Martin, Janet
    Sabharwal, Mona
    Gadhok, Anita
    Stevenson, Helen
    Coyle, Doug
    VALUE IN HEALTH, 2012, 15 (06) : 982 - 986
  • [32] Rare diseases and orphan drugs: Latvian story
    Konstantins Logviss
    Dainis Krievins
    Santa Purvina
    Orphanet Journal of Rare Diseases, 9
  • [33] Orphan drugs and rare diseases: a multifaceted story
    Simoens, Steven
    EJHP PRACTICE, 2010, 16 (04): : 18 - 18
  • [34] Rare diseases and orphan drugs: difficulties and perspectives
    Cannizzaro, Emanuele
    Tranchina, Ernesto
    Cannizzaro, Gaspare
    ACTA MEDICA MEDITERRANEA, 2007, 23 (02): : 65 - 68
  • [35] Rare diseases, orphan drugs, and orphaned patients
    Scheindlin, Stanley
    MOLECULAR INTERVENTIONS, 2006, 6 (04) : 186 - 191
  • [36] A POLICY FRAMEWORK FOR FUNDING DRUGS FOR RARE DISEASES
    Clarke, J.
    Bell, C.
    Coyle, D.
    Stevenson, H.
    Evans, G.
    Martin, M. J.
    Sabharwal, M.
    Gadhok, A.
    Winquist, E.
    VALUE IN HEALTH, 2009, 12 (07) : A243 - A243
  • [37] WHICH EFFICACY TRIALS FOR DRUGS FOR RARE DISEASES?
    Traversa, Giuseppe
    Trotta, Francesco
    EPIDEMIOLOGIA & PREVENZIONE, 2017, 41 (5-6): : 318 - 319
  • [38] RARE DISEASES, ORPHAN DRUGS, AND THE LEGISLATION IN CHINA
    Zhang, Y. J.
    Guo, J. J.
    Wang, J. B.
    VALUE IN HEALTH, 2010, 13 (07) : A533 - A533
  • [39] Rare Diseases, Orphan Drugs, and the Legislation in China
    Zhang, Yanjun
    Zhang, Yan-De
    Wang, Jing-Bo
    Guo, Jeff J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S257 - S258
  • [40] Generic Competition for Drugs Treating Rare Diseases
    Beall, Reed F.
    Quinn, Amity E.
    Kesselheim, Aaron S.
    Tessema, Frazer A.
    Sarpatwari, Ameet
    JOURNAL OF LAW MEDICINE & ETHICS, 2020, 48 (04): : 789 - 795